Kala Bio KALA
NASDAQ KALA
$0.38 -0.04 (-9.52%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kala Bio (KALA) Selling, General & Administrative (2016 - 2026)

Updated

Kala Bio's Selling, General & Administrative came in at $1.66 million for Q2 2026, down 64.2% from $4.64 million a year earlier and down 4.5% from the prior quarter.

Analysis

Kala Bio (KALA) Selling, General & Administrative (2016 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Kala Bio reported Selling, General & Administrative of $17.8 million, down 0.2% year-over-year; for FY2025, it came in at $23.63 million, up 28.8% from FY2024.

  • Selling, General & Administrative carries a five-year compound annual growth rate of -21.9% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $18.34 million in FY2024 (-10.8%), $20.57 million in FY2023 (-68.4%), $65.04 million in FY2022 (-38.1%) and $105.06 million in FY2021 (+29.6%).
  • The Q2 2026 figure represents the lowest quarterly Selling, General & Administrative since Q2 2017.
  • Year-over-year, Selling, General & Administrative increased in three of the last eight quarters, with an average decline of 2.1%.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q4 2025 (growth of 134.7%), and the weakest in Q2 2023 (a decline of 78.1%).
  • Business Quant data shows KALA's Selling, General & Administrative at $1.74 million (Q1 2026), $9.86 million (Q4 2025) and $4.53 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Kala Bio 5.81 Mn 5.81 Mn - 1.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.66 Mn
Mar 31, 2026 1.74 Mn
Dec 31, 2025 9.86 Mn
Sep 30, 2025 4.53 Mn
Jun 30, 2025 4.64 Mn
Mar 31, 2025 4.59 Mn
Dec 31, 2024 4.20 Mn
Sep 30, 2024 4.40 Mn
Jun 30, 2024 4.32 Mn
Mar 31, 2024 5.42 Mn
Dec 31, 2023 4.62 Mn
Sep 30, 2023 4.95 Mn
Jun 30, 2023 4.96 Mn
Mar 31, 2023 6.03 Mn
Dec 31, 2022 5.83 Mn
Sep 30, 2022 9.55 Mn
Jun 30, 2022 22.67 Mn
Mar 31, 2022 26.98 Mn
Dec 31, 2021 24.03 Mn
Sep 30, 2021 25.35 Mn
API Access

Kala Bio Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KALA&period=max&api_key=YOUR_API_KEY